{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-000209","form_type":"8-K","ticker":"FLNA","cik":"0001069530","company_name":"FILANA THERAPEUTICS, INC.","filed_at":"2024-01-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.280785+00:00","generated_at":"2026-06-07T04:29:01.444310+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Cassava Sciences distributes warrants to common shareholders; each 10 shares get 4 warrants exercisable at $33","bullets":["Distribution of warrants to holders of record as of Dec 22, 2023, at ratio of 4 warrants per 10 common shares.","Each warrant allows purchase of one share at $33, plus a bonus of 0.5 additional shares if exercised before bonus expiry.","Warrants expire Nov 15, 2024; redeemable by company after Apr 15, 2024 at 1/10 of $0.01 per warrant.","Warrants expected to trade on Nasdaq under ticker SAVAW starting Jan 4, 2024.","Prospectus supplement filed to register 24,342,150 shares of common stock for issuance upon warrant exercise."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-000209","json":"https://secwatch.observer/filing/0001493152-24-000209.json","markdown":"https://secwatch.observer/filing/0001493152-24-000209.md","text":"https://secwatch.observer/filing/0001493152-24-000209.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1069530/000149315224000209/0001493152-24-000209-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1069530/000149315224000209/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T04:29:01.444310+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d59712bd59003717c1bfd5cf382b34e4faa8ccff","claim":"FILANA THERAPEUTICS, INC. entered into Warrant Agreement with Computershare Inc. and Computershare Trust Company, N.A. valued at Warrants to purchase shares of Common Stock at an Exercise Price of $33.00 per Warrant, with a Bonus (effective 2024-01-03).","evidence_excerpt":"On December 12, 2023, Cassava Sciences, Inc., a Delaware corporation (the \" Company \"), announced that the Board of Directors of the Company declared a distribution (the \" Warrant Distribution \") to the holders of record of the Company's shares of common stock, par value $0.001 per share (the \" Common Stock \"), in the form of warrants to purchase shares of Common Stock (the \" Warrants \").","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1069530/000149315224000209/0001493152-24-000209-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"Computershare Inc. and Computershare Trust Company, N.A."},{"label":"Value","value":"Warrants to purchase shares of Common Stock at an Exercise Price of $33.00 per Warrant, with a Bonus"},{"label":"Effective","value":"2024-01-03"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}